Orano Med Opens Europe’s First Lead-212 Alpha Therapy Production Facility
Orano Med Inaugurates ATLab Valenciennes, Europe’s First Industrial-Scale Facility for Lead-212 Targeted Alpha Therapies Orano Med, a subsidiary of the Orano Group and a pioneer in targeted alpha therapies for…
ILiAD Biotechnologies Publishes Pediatric BPZE1 Phase 2b Data in The Lancet Infectious Diseases
ILiAD Biotechnologies Publishes Phase 2b SUPER Trial Results for Intranasal Pertussis Vaccine Candidate BPZE1 in The Lancet Infectious Diseases ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical-stage biotechnology company focused on…
Verastem Oncology to Present New RAMP 201 Data on Avutometinib in LGSOC at IGCS 2026
Verastem Oncology Presents New Data Supporting Avutometinib Plus Defactinib Across Molecular Subgroups in Recurrent LGSOC Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company focused on developing new medicines for patients with…
LISTERINE® Launches Oral Care Counts on World Smile Day as Global Oral Disease Cases Reach 3.73 Billion
LISTERINE® Launches Oral Care Counts Initiative to Highlight the Essential Role of Oral Health in Overall Wellbeing LISTERINE® is launching Oral Care Counts, a multiyear education and advocacy initiative designed…
AngioDynamics and PERT Consortium Name Jacobi Hospital ALPHA-PE Research Award Recipient
AngioDynamics Supports Jacobi Hospital Study Investigating CT Pulmonary Angiography Radiomics in Pulmonary Embolism AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring blood flow within the vascular system,…
Italfarmaco and JCR Pharma Partner on Novel Hunter Syndrome Therapy
Italfarmaco and JCR Pharmaceuticals Enter Exclusive Agreement to Advance JR-141 for Hunter Syndrome in Global Markets Italfarmaco S.p.A. and JCR Pharmaceuticals Co., Ltd. (TSE: 4552) have entered into an exclusive…
Summit Therapeutics Partners with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab Plus Datroway in Clinical Trial
Summit Therapeutics, Daiichi Sankyo and AstraZeneca Launch Clinical Collaboration to Evaluate Ivonescimab and Datroway in Solid Tumors Summit Therapeutics Inc. (Nasdaq: SMMT) has announced a clinical trial collaboration agreement with…
Blue Matter Launches Behavioral Science Center of Excellence to Predict Health Care Decisions in Biopharma
Blue Matter Launches Behavioral Science Center of Excellence to Strengthen Biopharma Market Research and Decision-Making Blue Matter has announced the launch of its Behavioral Science Center of Excellence (BeSci CoE),…
Samsung Bioepis and Teva Expand Partnership to Develop Up to Six Biosimilar Candidates
Samsung Bioepis and Teva Expand Global Biosimilar Partnership to Advance Up to Six Candidates Samsung Bioepis Co., Ltd. and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) have announced an…
Medical Affairs Leaders Convene in Boston to Chart the Future of Digital Innovation and Ethics in Healthcare Technology
As artificial intelligence moves from pilot projects to everyday practice across the life sciences industry, the Medical Affairs Professional Society (MAPS) will bring together leaders from pharma, biotech and MedTech…
ICUS Review Challenges “State Law” Myth on Sonographer Use of Ultrasound Contrast Agents
ICUS Review Finds No State Law Explicitly Bans Credentialed Sonographers From Administering Ultrasound Contrast The International Contrast Ultrasound Society (ICUS) has released a comprehensive review of statutes and regulations covering…
Qurient Publishes Q901 CDK7 Inhibitor Data in Science Advances
Qurient Study in Science Advances Shows Q901 Can Enhance TOP1-Targeting ADC Activity Qurient Co., Ltd. (KRX: 115180), a clinical-stage biotechnology company focused on developing innovative cancer therapies, has announced the…